Lobectomy for non-small cell lung carcinoma: a nationwide study of short- and long-term survival.

• Published in: Acta Oncologica
• Main Authors: Oskarsdottir, G N, Halldorsson, H, Sigurdsson, M I, Fridriksson, B M, Baldvinsson, K, Orrason, A W, Jonsson, S, Planck, M, Gudbjartsson, T
• Other Authors: 1 a Departments of Cardiothoracic Surgery , Landspitali University Hospital , Reykjavik , Iceland. 2 b Department of Pulmonology , Skåne University Hospital , Lund , Sweden. 3 c Departments of Pulmonology , Landspitali University Hospital , Reykjavik , Iceland. 4 d Faculty of Medicine , University of Iceland , Reykjavik , Iceland.
• Format: Article in Journal/Newspaper
• Language: English
• Published: Informa Healthcare 2017
• Subjects: Lungnakrabbamein; Skurðlækningar; Lífslíkur; TAS12; PAD12; Lung Neoplasms; Pulmonary Surgical Procedures; Survival; Iceland; Meier; Smella; TNM
• Online Access: http://hdl.handle.net/2336/620165; https://doi.org/10.1080/0284186X.2017.1304652

Efst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn Lobectomy is the standard curative treatment for non-small cell carcinoma (NSCLC) of the lung. Most studies on lobectomy have focused on short-term outcome and 30-day mortality. The aim of this study was to determi...